CID 1219971

132304-37-1

Structural Information

Molecular Formula
C10H16N4O2S
SMILES
CCC1=NN=C(S1)NC(=O)CN2CCOCC2
InChI
InChI=1S/C10H16N4O2S/c1-2-9-12-13-10(17-9)11-8(15)7-14-3-5-16-6-4-14/h2-7H2,1H3,(H,11,13,15)
InChIKey
MJIVQZAYPYEAII-UHFFFAOYSA-N
Compound name
N-(5-ethyl-1,3,4-thiadiazol-2-yl)-2-morpholin-4-ylacetamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

5
References

0
Patents

256.0994 Da
Monoisotopic Mass

0.4
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 257.10668 157.1
[M+Na]+ 279.08862 166.1
[M+NH4]+ 274.13322 163.5
[M+K]+ 295.06256 161.6
[M-H]- 255.09212 159.5
[M+Na-2H]- 277.07407 160.6
[M]+ 256.09885 159.1
[M]- 256.09995 159.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.